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We examine how industrial clustering affects biotechnology firms’ innovativeness, contrasting 
similar firms not located in clusters or located in clusters that are or are not focused on the firm’s 
technological specialization. Using detailed firm level data, we find clustered firms are eight 
times more innovative than geographically remote firms, with largest effects for firms located in 
clusters strong in their own specialization.   For firms located in a cluster strong in their 
specialization we also find that R&D productivity is enhanced by a firm’s own R&D alliances 
and also by the R&D alliances of other colocated firms.  
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The idea that collocation is beneficial to firms’ innovative success is central to theorizing about 
the benefits of industrial clusters in the new economic growth theory and the new economic 
geography.  Underlying the clustering phenomenon are mechanisms that facilitate the interchange 
and flow of information between firms, while maintaining inter-firm rivalry (Porter, 1990).  If the 
transfer of technological knowledge is greatest for firms in close geographic proximity, then 
location within a cluster of related firms in a limited geographic neighborhood is expected to 
enhance productivity.   
Central to this argument is the idea that certain locations provide localized knowledge 
externalities or spillovers that provide positive economic value.  Because new technological 
knowledge is elusive and uncodified, geographic concentrations of innovative activity generate 
more knowledge spillovers and, therefore, more innovative output (Feldman, 1994; Audretsch & 
Feldman, 1996).  The fact that spillovers associated with R&D activity are geographically 
bounded helps to account for the clustering process and to explain spatial differences in rates of 
innovation and the distribution of economic growth.  The significance of localized knowledge 
spillovers as innovative inputs suggests that firms’ R&D activities do not proceed in isolation, 
but depend on access to new ideas.   
Firms that depend on innovation for their success and survival thus not only face a series 
of strategic decisions about the organization of their own R&D resources, including what types of 
strategic alliances to form but also may consider how colocation among related firms affects their 
productivity.  Earlier studies have modeled firms’ entry, growth and innovative output as a 
function of the strength of the cluster in which they are located, examining whether strong 
clusters tend to attract a disproportionate number of startups, and are responsible for a 
disproportionate share of innovative output (e.g., Baptista & Swann, 1998, 1999; Beaudry, 2001; 
Beaudry & Breschi, 2003; Swann & Prevezer, 1996).  These studies yielded a number of 
important findings, most notably, that, compared to more isolated firms, firms located in clusters 
that were strong in their own broadly defined (2-digit) industry tended to grow faster and produce 
more innovations, while firms located in clusters that were strong in other (2-digit) industries did 
not.  What these studies do not consider, however, is why this is the case: data limitations prevent 
estimation of firms’ relative benefit from knowledge spillovers when compared to similar firms 




firms may use to source knowledge and overcome geographic isolation is through the formation 
of strategic alliances yet there has been limited investigation of how this firm strategy relates to 
geographic location and if strategic alliances provide substitutes or complements for colocation. 
In this paper, we exploit a unique, longitudinal dataset on the Canadian biotechnology 
industry that includes comprehensive firm level information to examine how a firm’s innovative 
output (patent application rate) is affected by its own and other collocated firms’ R&D inputs 
(R&D expenditures, R&D employees and R&D alliances).  We contrast the effects of these R&D 
inputs for firms located in clusters that were strong in their technological specialization (e.g., 
agriculture, aquaculture, human therapeutics) with the effects for firms located in clusters that 
were not strong in their specialization.  This permits us to examine the extent to which the greater 
innovativeness of firms located in clusters strong in their own technology specialization result, at 
least in part, from their earning greater returns to R&D activity as a result of enhanced knowledge 
spillovers.  
Our study makes four additional empirical contributions made possible by our 
comprehensive firm-level data.  First, whereas data limitations have limited prior studies’ ability 
to control for firm heterogeneity, we are able to specify a detailed firm-level baseline model to 
help ensure that observed clustering benefits are not spuriously capturing uncontrolled firm 
characteristics.  Second, our detailed firm level information enables us to model the influence of a 
broader range of cluster characteristics on innovative output than past research, which has 
focused primarily on cluster employment.  Third, we are able to specify firms’ technological 
specializations in a much more fine-grained way than most past studies, which have relied on 
much broader industry or sector definitions that made it difficult to draw strong conclusions 
about own and cross-sector spillover effects.  And fourth, we identify geographic clusters 
empirically based on the relative geographic locations of individual firms, permitting us to 
examine clustering effects over compact geographic areas.  After all, we expect that clusters will 
be defined by the self-organization of firms.  Data constraints have forced most past studies to 
examine cluster-related effects based on predefined administrative or statistical units such as 
states or metropolitan areas despite evidence that spillovers and other agglomeration externalities 
are stronger in smaller geographic areas (Jaffe et al., 1993). 
Biotechnology is a type of industrial activity that would most benefit from the types of 




Biotechnology is likely to experience localization economies because much of its knowledge 
base is tacit and uncodifiable, the precise conditions that favor knowledge spillovers in 
agglomeration economies.  Moreover, biotechnology is an industry that relies heavily on patents 
to protect intellectual property.   Although the problems with patents as an output measure are 
well-known (Griliches, 1979; Scherer, 1984), they are a critical measure of inventive output for 
firms in the biotechnology industry with its often long delays in bringing products to market. 
Since many firms have not yet achieved profitability the ability to patent is a measure of the 
firms’ success (Lerner, 1994).  Patent applications are preferable to the alternative of firm growth 
since externalities related to knowledge should manifest themselves primarily on inventive output 
(Baptista & Swann, 1998).   
 
Clustering and Firms’ Innovative Output 
The last decade has witnessed great interest in the topic of economic growth at the 
macroeconomic level (Romer, 1986; 1990).  A complementary literature examines the growth of 
cities and suggests that localization economies increase growth within cities (Glaeser et al. 1994; 
Audretsch & Feldman, 1999).  The benefits of clustering can be further divided into demand and 
supply factors (Baptista & Swann, 1998).  On the demand side, firms may cluster to take 
advantage of strong local demand, particularly from related industries.  Under certain conditions, 
firms can gain market share if they locate closer to competitors as originally suggested in 
Hotelling’s (1929) celebrated analysis. Such gains may be short-lived, however, as more firms 
collocate, congestion results and incumbents react with intensified competition. 
On the supply side, the main sources of location externalities can be traced to Marshall 
(1920) and Arrow (1962) and were restated by Romer (1986, 1990), and are usually referred to in 
the literature as MAR (Marshall-Arrow-Romer) externalities (Glaeser et al., 1994).  These ideas 
have been augmented by recent work in the new economic geography (see for reviews Baptista, 
1998; Feldman, 2000) and are reflected in Krugman’s (1991) widely known work on geography 
and trade.  MAR externalities include benefits of a pooled labor supply, access to specialized 
inputs and information flows between people and firms.  Geographical concentration of firms in 
the same industry creates a market for skilled workers and specialized inputs and may lower the 
cost of inputs specific to an industrial specialization.  The most significant supply-side 




related to the diffusion of knowledge between neighboring firms.   
One of the most important findings in the new economic geography is that knowledge 
spillovers provide a mechanism for enhancing the innovative performance and growth of firms.  
Knowledge spillovers arise from industry specialization as knowledge created in one firm aids 
the advancement of other, technologically similar firms.  Geographic proximity creates 
opportunities for face-to-face interactions and trust building essential to the effective exchange of 
ideas.  Moreover, uncodified knowledge leads to localized interaction to the sources of novel 
scientific knowledge such as universities and public research laboratories (Audretsch & Feldman, 
1996; Jaffe, 1989) and promotes networking of firms engaged in related research (Powell et al., 
1996).  The cumulative nature of innovation manifests itself not just at firm and industry levels, 
but also at the geographic level, creating an advantage for firms locating in areas of concentrated 
innovative activity, and leading innovation to exhibit pronounced geographical clustering.  These 
factors can generate positive feedback loops or virtuous cycles as concentration attracts 
additional labor and other inputs as well as greater exchange of ideas (Krugman, 1991). 
Industries that are geographically clustered should thus benefit most from knowledge 
spillovers, and geographic proximity to concentrations of similar firms should increase 
innovation at the firm level.  We expect, therefore, that after controlling for firm specific 
characteristics:  
Hypothesis 1 (H1).  Innovative output of biotechnology firms located within 
geographic clusters is greater than the innovative output of those located outside 
such clusters.   
 
Clustering and Technological Specialization 
It is, however, not only geographic clustering per se that produces enhanced innovative output.  
The importance of knowledge spillovers and information sharing on innovative activity suggest 
that industries that are both spatially clustered and technologically specialized should produce the 
greatest benefit for firms.  Baptista and Swann (1998, 1999), for example, found that firms 
located in clusters with a concentration in their own (two-digit) industry sector produced more 
patents than geographically isolated firms in the biotechnology and computer industries.   




patenting.  Wallsten (2001) provides similar results showing that positive spillovers are greater 
among neighboring firms operating in the same technology area (e.g., computing, electronics, 
materials, energy conversion, life sciences) than across technology areas.   
It is difficult to draw conclusions about the spillover effects of own and other sector 
effects based on such high levels of aggregation, however.  Knowledge spillover arguments 
suggest a more fine-grained specialization, and the effects of own and other sector concentrations 
likely depend on the technological distance and complementarity of technological specializations.  
As Almeida and Rosenkopf (2003) recently found, for example, patent citation patterns within 
the semiconductor industry are technologically (as well as geographically) localized such that 
firms patenting in more similar classes were more likely to cite each other’s patents.  Thus, even 
within the same industry there is evidence that specific technological specializations matter, 
suggesting that greater and more interpretable evidence of knowledge spillovers will be found by 
examining different technological or industrial specializations within one industry.  
Although biotechnology is often used to describe an industry, it is more aptly a 
technology for manipulating microorganisms that overtime is manifested in different specialized 
applications in different industrial sectors (agriculture, aquaculture, food and beverage, and 
human therapeutics, for example).
1  And, that the cumulativeness of technological advances and 
the properties of the knowledge base differ across these different specializations, rendering 
positive spillovers stronger within than across specializations.  Thus, the more closely related 
biotechnology firms are in terms of their particular technological specializations, the more likely 
their concentration is to create virtuous, self-reinforcing effects, and exhibit greater productivity 
effect due to spillovers.  
Consequently, we expect that biotechnology firms located in clusters that are strong in 
their own specialization should benefit more from proximity than firms located in clusters that 
are strong in other specializations.   
Hypothesis 2 (H2).  Innovative output of biotechnology firms located in clusters 
that are strong in their own technological specialization is greater than the 
innovative output of those located in clusters strong in other specializations.    
 
                                                 
1  Notably, studies of the biotechnology industry frequently consider only firms working in human health 




Clustering and the Returns to Firms’ Own and Other Firms’ R&D Activities 
Hypothesis 2 begs the question:  What are the precise advantages provided by geographic 
proximity to creative, knowledge intensive innovative activity?  As Balconi et al. (2004) note, we 
still know little about knowledge transport mechanisms.  Informal conversations and personal 
social networks are, however, widely believed to be vital mechanisms for transferring knowledge 
and ideas between firms.  Networks play an important part in many economic phenomena, and 
one area in which networks are particularly important is the diffusion of information and 
knowledge.  The tacitness of cutting-edge knowledge highlights that successfully applying 
knowledge to commercial activity entails an intensive and costly investment (Nightingale 1998).  
Collins (1974), for example, found that even after publication of results, no scientist was able to 
build a TEA laser without having first spoken directly with members of the original research 
team.  Even patents, which contain codified knowledge, exhibit a strong geographic element to 
their diffusion.  Jaffe et al. (1993), for example, find that patent citations are more likely to come 
from within the same state and SMSA, arguing that this reflects underlying patterns of research 
activity.  Almeida and Rosenkopf (2003) recently found a similar pattern of geographically 
localized patent citations in the U.S. semiconductor industry.   
Diffusion of knowledge and ideas tends to be local rather than global, and for early stage 
technological specializations when tacitness is high, face-to-face contact becomes increasingly 
essential to effective knowledge transfer.  Concentrating people engaged in related activities in a 
particular location thus creates an environment that facilitates the rapid and effective diffusion of 
ideas.  Close proximity may thus not only be helpful in capturing knowledge spillovers – but 
necessary.   
Taken together, these ideas about transport mechanisms suggest that, whatever the 
mechanism, strong clusters exist because concentrating the R&D activities of firms facilitates 
knowledge spillovers in a given technological specialization, thereby increases the productivity 
of R&D activity – R&D expenditures, R&D employees and R&D alliances – for each firm in the 
concentration.  Moreover, research shows that firms that conduct their own R&D are better able 
to use externally available information (e.g., Mowery, 1983); suggesting that absorptive capacity 
– the ability to exploit external knowledge – is created as a byproduct of a firm’s R&D 
investment (Cohen & Levinthal, 1990).  R&D experience enables a firm to recognize and exploit 




R&D thus not only generates new knowledge but also contributes to its absorptive capacity.  This 
suggests that the greater innovativeness of firms located in clusters that are strong in their own 
technological specialization results not only from their earning greater returns to their own R&D 
activity but also from a key source of the spillovers: the R&D activities of other firms working on 
the same technological specialization.  Therefore, we hypothesize:  
Hypothesis 3 (H3).  A biotechnology firm’s innovative output is enhanced more 
by its own R&D activities when it is located in a cluster that is strong in its own 
technological specialization than when it is located in a cluster strong in 
another specialization.  
Hypothesis 4 (H4).  A biotechnology firm’s innovative output is enhanced more 
by the R&D activities of other firms in the same technological specialization 
when it is located in a cluster that is strong in its own specialization than when it 
is located in a cluster strong in another specialization. 
An alternative interpretation of the forgoing argument is that, rather than enhancing the 
value of a firm’s own R&D activities, the positive externalities afforded a firm located in a 
cluster strong in its own technological specialization renders the firm’s own R&D activities 
redundant.  That is, that cluster membership may substitute for a firm’s own R&D activity (Acs 
et al. 1994).  For example, while R&D alliances may represent important conduits for the 
exchange of ideas and knowledge, firms located in clusters that are strong in their own industrial 
specialization may use informal networks and interactions instead, which would decrease the 
need for such formal collaborative arrangements.  In the same way, greater informal exchange of 
ideas among R&D employees across firm boundaries may substitute for the exchange of ideas 
among R&D employees within a firm’s boundaries.  If this were the case, in contrast to 
hypotheses 3 and 4, we would expect that firms located in clusters that are not strong in their own 
industrial specialization benefit more from R&D alliances and investments in R&D employees.  
When firms do not have access to the informal networks and interactions that characterize the 
strong geographic R&D concentration they may compensate with formal strategic alliances. 
Moreover, at the cluster level, it is also likely that there are limits to the positive 
externalities by which clusters are self-reinforced, and that as a cluster grows, congestion and 




greater positive externalities, more R&D activity by firms in the same industry may generate 
greater competition among firms in the cluster for, for example, skilled R&D employees 
(Baptista & Swann, 1998) or R&D alliance partners (Silverman & Baum, 2000) and so impedes, 
rather than enhances a firm’s innovative output.  Altogether, these ideas suggest the following 
alternative hypotheses: 
Hypothesis 3alt (H3alt).  A biotechnology firm’s innovative output is enhanced 
less by its own R&D activities when it is located in a cluster that is strong in its 
own technological specialization than when it is located in a cluster strong in 
another specialization. 
Hypothesis 4alt (H4alt).  A biotechnology firm’s innovative output is enhanced 
less by the R&D activities of other firms in the same technological specialization 
when it is located in a cluster that is strong in its own specialization than when it 
is located in a cluster strong in another specialization. 
 
Data Description 
We tested our hypotheses using data on the 675 biotechnology firms operating in Canada at any 
time between January 1991 and December 2000.  The sample included 204 startups founded 
during the period (of which 69 had ceased operations by December 2000) and 471 incumbents 
founded prior to 1991 (of which 195 had ceased operations by December 2000).  We compiled 
our data using Canadian Biotechnology, an annual directory of Canadian firms active in the 
biotechnology field published since 1991. Canadian Biotechnology is the most comprehensive 
historical listing in existence of Canadian biotechnology firms, providing information on their 
management, products, growth, performance, alliances and locations. We cross-checked this 
information with The Canadian Biotechnology Handbook (1993, 1995, 1996), which lists 
information for a more restrictive set of core firms entirely dedicated to biotechnology.   
Data on financings of biotechnology firms by venture capital firms and through private 
placements were compiled separately by the National Research Council of Canada (NRC).
2  Data 
on patents issued to each firm between 1975 and 2002 using the Micropatent database (which 
                                                 




begins in 1975).  We used U.S. patent data because Canadian firms typically file patent 
applications in the U.S. first to obtain a one-year protection during which they file in Canada, 
Europe, Japan and elsewhere (Canadian Biotech '89; Canadian Biotech '92).  
 
Geographic Cluster Identification 
Rather than using predefined geographic units to identify clusters, we identified clusters 
empirically based on the relative distances between individual biotechnology firms across Canada 
in each observation year.  This permits us to examine clustering effects over more compact 
geographic areas than most prior studies (an exception is Wallsten, 2001), which typically 
examine clustering effects using political jurisdictions such as states or counties or statistical 
units such as MSAs (Metropolitan Statistical Area) SMSAs (Standard Metropolitan Statistical 
Area).  Segmenting the data in this way produces arbitrary spatial boundaries that can bisect 
clusters, ignoring the presence of any firms that fall beyond the arbitrary geographic boundary 
even if they lie very near to the borderline, and so generate inaccurate measures of the true levels 
of local industrial concentration.  The logic of clusters suggests that firms will seek to locate be 
nearby similar entities based on proximity rather than on jurisdictional attributes.  In our 
conceptualization firms self-organize, choosing locations as a strategic decision.    
To identify clusters, we first converted each firm’s six-character postal code address into 
latitude and longitude measurements.
3  In urban areas, a single postal code corresponds to one of 
the following: one block-face (i.e., one side of a city street between consecutive intersections 
with other streets – approximately 15 households); a Community Mail Box; an apartment 
building; an office building; a large firm/organization; a federal government department, agency 
or branch (Statistics Canada, 2001 Census).
4  A zip code, by comparison, covers a considerably 
larger geographic area.  Stuart and Sorenson (2003), for example, report that the mean area 
                                                 
3 The form of the postal code is “ANA NAN”, where A is an alphabetic character and N is a numeric character. The 
first character of a postal code represents a province or territory, or a major sector entirely within a province.  If the 
second character is ‘0’, the FSA is rural.  The first three characters of the postal code identify the forward sortation 
area (FSA). Individual FSAs are associated with a postal facility from which mail delivery originates. The average 
number of households served by an FSA is approximately 7,000.  As of May 2001, there were approximately 1,600 
FSAs in Canada (1,400 urban; 200 rural). The last three characters of the postal code identify the Local Delivery 
Unit (LDU). Each LDU is associated with one type of mail delivery (for example, letter carrier delivery, general 
delivery) and it represents one or more mail delivery points. The average number of households served by an LDU is 
approximately 15. As of May 2001, there were more than 750,000 Local Delivery Units. 




covered by a zip code in their study of biotechnology firm foundings is 27.4 square miles (44.41 
kilometers).  MSAs are larger still, with the mean area of an MSA in the U.S. equal to 10,515 
square miles (17,042 kilometers). 
We calculated distance by representing firms in space according to their latitudes and 
longitudes adjusted for the earth’s curvature.  Over short distances, Euclidian distances would 
accurately measure the distance between two locations; however, the curvature of the earth 
seriously affects these calculations over areas as large as Canada.  Therefore, we calculated 
distances using spherical geometry (Ng, Wilkins & Perras, 1993; Stuart & Sorenson, 2003), 
which computes the distance between two points A and B as:  
d(A,B) = 6370.997 × {arccos[sin(latitudeA) × sin(latitudeB) + cos(latitudeA) × cos(latitudeB) × 
cos(|longitudeA – longitudeB|)]}, 
where latitude and  longitude are measured in radians. The constant, 6370.997 is the earth’s 
radius in kilometers, and converts the distance into units of one kilometer. 
Based on these measures, we constructed distance matrices comparing the location of 
each firm to every other firm in the population in a given year.  We used these matrices as input 
for a cluster analysis that grouped firms by minimizing within-group average distance. Despite 
the substantial turnover of firms, the analysis consistently yielded thirteen distinct geographic 
clusters in each observation year.   
In each year, we compared each firm’s mean within-cluster distance to the overall cluster 
mean, and excluded from the cluster all firms whose average distance was two or more standard 
deviations above the cluster average.  Firms within the two standard deviation cutoff for their 
cluster within a given year were considered members of that cluster in that year.  This process 
eliminated 6.2 percent of the firm-year observations from a cluster.  The resulting clusters were 
remarkably compact, with the distance between the remaining firms located within each cluster 
averaging 31.7 kilometers (19.7 miles), and ranging from 1.15 to 83.19 kilometers (0.71 to 51.69 
miles).
5  Figure 1 shows the geographic distributions of biotechnology firms in Canada for 1991 
and 2000, and the geographic locations included within each of the empirically derived clusters 
for these years.  Overall, the industry is highly clustered within a small number of compact areas.  
                                                 
5 We examined the robustness of our results to this cutoff by using the overall mean distance for all clusters and 
defining outliers as firms that are more than two standard deviations from the overall mean.  This cutoff tends to 
leave smaller clusters intact, while removing more distant firms from larger clusters, making them more compact. 




Insert Figure 1 about here. 
 
Strong Technological Specialization  
We identified each cluster’s strong industry technological specialization(s) based on the 
proportions of firms in the cluster working in each technological specialization.  The sixteen 
specializations in which Canadian biotechnology firms operate are:  (1) agriculture, (2) 
aquaculture, (3) horticulture, (4) forestry, (5) engineering, (6) environmental, (7) food, beverage 
and fermentation, (8) veterinary, (9) energy, (10) human diagnostics, (11) human therapeutics, 
(12) human vaccines (13) biomaterials, (14) cosmetics,  (15) mining and (16) contract research.  
Insert Figure 2 about here. 
Figure 2 plots the distribution of firms by cluster (labeled based on the province in which 
the majority of firms reside) among seven of the above industry technological specializations 
covering over 85 percent of the sample firms.  The figure indicates that the majority of clusters 
are dominated by activity in human therapeutics and/or human diagnostics.  Exceptions include 
the Saskatchewan and Alberta-2 with concentrations in agriculture, Quebec-2 and New 
Brunswick with concentrations in engineering, and Nova Scotia, Prince Edward Island and 
Newfoundland with concentrations in aquaculture.  Based on the distribution in Figure 2, we 
defined a cluster’s strong technological specialization(s) as those in which more than 25 percent 
of its member firms operated.
6  To distinguish firms in their cluster’s strong technological 
specialization, we used a dummy variable coded one if the firm’s specialization was strong in its 
cluster, and zero otherwise. 
 
Dependent Variable and Analysis 
The dependent variable in our analysis is a firm’s yearly number of patent applications. Because 
this variable is a count measure, we used the pooled cross-section data to estimate the number of 
patent applications expected to occur within a given interval of time (Hausman, Hall & 
Griliches,1984).  A  Poisson process provides a natural baseline model for such processes and is 
                                                 
6 We examined the robustness of our results to this cutoff with a 20 percent cutoff as well as with continuous 
percentage variables.  The empirical estimates are not substantively different from the estimates presented in Tables 




appropriate for relatively rare events (Coleman, 1981). The basic Poisson model for count data is: 
Pr(Yt = y) = exp λ(xt)[λ(xt)y/y!] 
where both the probability of a given number of events in a unit interval, Pr(Yt = y) and the 
variance of the number of events in each interval equal the rate, λ(xt). Thus, the basic Poisson 
model makes the strong assumption that there is no heterogeneity in the sample. However, for 
count data, the variance may often exceed the mean.  Such overdispersion is especially likely in the 
case of unobserved heterogeneity. The presence of overdispersion causes the standard errors of 
parameters to be underestimated, resulting in overstatement of levels of statistical significance. In 
order to correct for overdispersion, the negative binomial regression model can be used. A common 
formulation, which allows the Poisson process to include heterogeneity by relaxing the assumption 
that the mean and variance are equal is:  
λt = exp(π'xt)εt 
where the error term, εt, follows a gamma distribution. The presence of εt produces overdispersion. 
The specification of overdispersion we use takes the form: 
Var(Yt) = E(Yt)[1+αE(Yt)] 
We estimated the model using a specification that accounts for the potential non-independence of 
the repeated observations on each firm.  A further estimation issue concerns sample selection bias 
due to attrition: if a firm fails, it leaves the sample without its final activities represented in the 
data. Therefore, we estimated models that corrected for possible sample selection bias due to 
attrition using Lee’s (1983) generalization of Heckman’s (1979) two-stage procedure. 
 
Independent Variables 
We operationalized a biotechnology firm’s investment in inventive activity using three measures: 
1) R&D expenditures (in 1991 Canadian dollars, logged to normalize the distribution), 2) number 
of R&D employees (logged to normalize the distribution), and 3) number of R&D alliances with 
other biotechnology firms.  We operationalized three analogous cluster-level variables computed 
based on the aggregate R&D expenditures, employees and alliances of other firms working in the 
same technological specialization in the cluster.  Aggregate R&D expenditures and employees 




All independent variables were measured annually, and lagged one year in the analysis to 
avoid simultaneity problems. 
 
Control Variables 
Many other factors may influence the innovative output of biotechnology firms, which if 
uncontrolled, may lead to spurious findings for our theoretical variables.  Accordingly, we 
control for a variety of additional firm, cluster, and other cluster characteristics.  Unless otherwise 
indicated, all control variables were updated annually and lagged one year in the analysis to avoid 
simultaneity problems. 
  Firm Characteristics.   First, since biotechnology firms with well developed technological 
capabilities are likely to be more innovative than other firms (Amburgey et al., 1996), we control 
for a firm’s technological competence using a count of the number of patent applications made 
during the last 5 years.  For firms already operating in 1991, we used information on patent 
applications during the 1986-1990 time period when computing the counts for the years between 
1991 and 1995.  This 5-year count measure follows cutoffs used in prior research (Baum et al., 
2000; Podolny & Stuart, 1995; Podolny et al., 1996). 
A firm’s access to capital may also affect its ability to patent.  For independent firms, 
capital raised through venture capital investments and private placements are vital to supporting 
inventive activity.  Firms that are established as subsidiaries or joint ventures may have access to 
financial resources of their parent firm(s), and this may affect their level of inventive activity and 
likelihood of patenting.  Firms may also use their revenues to support their inventive activity.  
Another important source of capital for biotechnology firms in Canada is R&D grants 
from the NRC’s Industrial Research Assistance Program (IRAP), which provides funding (up to 
C$350,000 per year) and expert assistance for work on R&D projects emphasizing advancement 
of unproven technology.  Therefore, we controlled for the yearly total financing and IRAP grants 
received by a firm, as well as its annual revenues (all in 1991 Canadian dollars, logged to 
normalize the distribution).  We also include a dummy variable coded one for firms with access 
to the resources of a corporate parent firm or firms, and zero otherwise.  
Patent application rates may also vary by technological specialization.  In particular, 




in human therapeutics and vaccines where rigorous clinical trials and regulations reduce speed to 
market and somewhat less so for diagnostics (about half of which are in vitro and half in vivo) 
(Baum et al., 2000).  We control for patenting differences among firms focused on human 
medical specializations with a dummy variable coded one for firms in human therapeutics, 
vaccines and diagnostics, and zero otherwise. 
In addition to R&D alliances, biotechnology firms also establish downstream alliances for 
manufacturing and distribution with pharmaceutical firms, chemical firms, marketing firms, and 
upstream alliances for basic research with university labs, research institutes, government labs, 
and hospitals that may affect their patent application rate.  Downstream alliances link 
biotechnology firms to sources of complementary assets including distribution channels, 
marketing expertise and production facilities, as well as financing (Kogut, Shan & Walker, 1992).  
Upstream alliances link biotechnology firms to sources of research know-how and technological 
expertise that can prove critical to the successful discovery and patenting of new products or 
processes (Argyres & Liebeskind, 1998).  To control for possible effects of these alliances on 
inventive output, we include separate yearly counts of a firm’s number of upstream alliances and 
downstream alliances.   
Relatedly, we control, with a dummy variable, for whether or not the firm was a 
university spin-off.  University spin-offs may possess systematically better access to cutting-edge 
academic resources, or may benefit from university funds dedicated to technology transfer.  We 
also control for firm age, defined as the number of years since founding, in our models to ensure 
that any significant effects of the theoretical variables were not simply a spurious result of aging-
related processes. 
Finally, we control for a firm’s relative geographic proximity to other firms located within 
its cluster.  Specifically, we control for the difference between a firm’s average distance from 
others within its cluster, and the average distance between any two firms in the cluster.  We 
expect that firms with average distances greater than the cluster average will benefit less from 
their cluster membership. 
Own Cluster Same Specialization Characteristics.  At the cluster level, we controlled for 
a set of analogous variables by aggregating the annual financing, IRAP grants, revenues of other 
firms located in a firm’s cluster and working in the same technological specialization (all in 1991 




and downstream alliances.  We also controlled for inventive output at the cluster level by 
aggregating patent applications made during the last five years by other firms working in the 
same specialization in the cluster.  These patents may represent a key source of knowledge 
spillovers; alternatively, they may serve to foreclose more technological opportunities.   
In addition, we controlled for potential local competition using a count of the number of 
other firms located in the firm’s cluster working in the same technological specialization.   
Finally, prior research has shown that the proximity to sources of scientific discovery can 
enhance firms’ inventive output (e.g., Jaffe, 1989; Feldman, 1994).  Therefore, we control for the 
number of university research labs working in the same specialization and located within the 
geographic bounds of a firm’s cluster.  
Own Cluster Other Specialization Characteristics.  To account for the possibility that any 
own cluster same specialization effects we found were not spuriously capturing broader cluster-
level, but not specialization-specific effects, we recomputed each of the own cluster same 
specialization variables, by aggregating the same information for firms working in other 
specializations within the cluster.  
Other Cluster Same Specialization Characteristics.  Additionally, to ensure that any 
effects we found of clustering were not spuriously capturing a more diffuse (i.e., non-local) 
processes occurring at a national level, rather than cluster level, we recomputed each of the own 
cluster variables, by aggregating the same information for firms located in all other clusters.  
Table 1a gives descriptive statistics by geographic cluster.  Table 1b gives the descriptive 
statistics by firms’ cluster location status – in a cluster strong in its technology specialization, in a 
cluster not strong in its specialization, and not located within a cluster.  As the tables show, the 
clusters vary widely in their composition and characteristics, as do firms depending on their 
cluster location status. 
Insert Tables 1a and 1b about here. 
  Appendix Table A1 presents descriptive statistics and bivariate correlations for 
independent and control variables for the analysis of patent application rates.  Our analysis may 
be affected by moderate multicollinearity among some of our explanatory variables, which can 
result in less precise parameter estimates (i.e., larger standard errors) for the correlated 
explanatory variables but will not bias parameter estimates (Kennedy, 1992). Although moderate 




significance for correlated variables, making it difficult to draw inferences about the effects of 
adding particular variables to our models. Therefore, we estimate and test the significance of 
groups of variables in comparisons of a series of hierarchically nested regression models and 
examine coefficients’ standard errors for inflation to check that multicollinearity is not causing 
less precise parameter estimates (Kmenta, 1971).  Although we do observe a small degree of 
standard error inflation in relation to the interaction effects, our ability to judge the significance 
of individual coefficients is not materially diminished. 
 
Results 
Table 2 gives regression estimates differentiating the patent application rates of biotechnology 
firms located within and outside a geographic cluster.  Controlling for firm characteristics, the 
coefficient estimate for a dummy variable coded one for firms located within a cluster, and zero 
otherwise, is positive and highly significant.  Supporting hypothesis 1, this indicates that firms 
located within a geographic cluster out-patent those not located in a cluster.  The magnitude of 
the coefficient is sizeable, indicating that, independent of firm characteristics, the patent 
application rate is more than eight times higher for firms located in clusters (e
2.134= 8.45), ceteris 
paribus. 
Table 3a reports estimates for models comparing the patent application rates for firms 
located within a geographic cluster that is either strong in their own or another technological 
specialization.  Model 1 provides a baseline model that includes firm characteristics, including a 
dummy variable coded one for firms located in a cluster strong in their industrial specialization, and 
zero for firms located in clusters strong in a specialization other than their own, as well as the 
firm’s distance from other firms its cluster.  Models 2, 3 and 4 build clustering effects into the 
baseline, adding, respectively, characteristics of the firm’s own cluster in the same specialization, 
other specializations in the firm’s own cluster, and the other clusters to ensure that effects of the 
own cluster characteristics are not spuriously capturing a more diffuse set of processes unrelated 
to technological specializations or geographic proximity.  
In Table 3b, Models 5 through 8 add the strong specialization interactions to examine in 
more detail the effects of the concentration of R&D activity within clusters on firms’ patent 




own R&D activity and other firm’s R&D activity separately; Model 7 includes both.  Model 8 
drops the insignificant interactions with own and other firm’s R&D expenditures.  As likelihood 
ratio tests given in the table show, Model 8 provides a significant improvement over Model 4.  
Therefore, we interpret the interaction effects in Model 8, our best fitting model. 
The significant positive coefficient in the fully specified model for the Firm in Strong 
Specialization dummy variable supports hypothesis 2, which predicted that firms located in a 
geographic cluster strong in their industry specialization would out-patent firms located in 
clusters that were not concentrated in their specialization.  Although not as large as the effect of 
being located in a cluster, firms located in clusters that were strong in their technological 
specialization applied for patents at more than twice the rate of firms not located in clusters 
strong in their specialization (e
0.931= 2.54). 
Support for hypothesis 3 is mixed, but consistent across levels.  The significant negative 
coefficient for the Strong Specialization x Firm R&D Employees interaction supports hypothesis 
3alt.  The significant positive coefficient for the Strong Specialization x Firm R&D Alliances 
interaction supports hypothesis 3, however.  The coefficient for Strong Specialization x Firm 
R&D Expenditures is not significant.  The pattern of results is identical for hypothesis 4.  The 
significant negative coefficient for the Strong Specialization x Own Cluster Same Specialization 
R&D Employees interaction supports hypothesis 4alt, while the significant positive coefficient 
for the Strong Specialization x Own Cluster Same Specialization R&D Alliances interaction 
supports hypothesis 4.  The Strong Specialization x Own Cluster Same Specialization R&D 
Expenditures interaction is not significant.  
Figures 3a and 3b illustrate the implications of these interactions graphically.  Figure 3a 
shows that as a firm’s own and other same specialization firms’ R&D employees increase in 
number, patent application rates for firms located in clusters that are strong in their own 
technological specialization falls from 2.0 times greater than firms located in clusters that are not 
strong in their own specialization when a firm has three R&D employees (i.e., natural logarithm 
= 1), to 1.1 times greater when the firm’s number of R&D employees reaches 20 (i.e., natural 
logarithm = 3), and from 1.5 times greater when other same specialization firms’ have 55 R&D 
employees (i.e., natural logarithm = 4) to 0.73 times when other firms’ number of R&D 
employees reaches 245 (i.e., natural logarithm = 5.5).  




increase in number, patent application rates for firms located in clusters that are strong in their 
own technological specialization increases from 2.6 times greater than firms located in clusters 
that are not strong in their own specialization when a firm has no R&D alliances, to 27.4 times 
greater when the firm’s number of R&D alliances reaches five, and from 2.5 times greater when 
other same specialization firms’ have no R&D alliances to 16.3 times greater when other firms’ 
number of R&D alliances reaches 15. 
Taken together the estimates indicate that the greater innovativeness of biotechnology 
firms located in clusters that were strong in their own specialization stemmed from two 
mechanisms.  One is that they earned greater returns to their own R&D alliances and from the 
R&D alliances of other firms in the same specialization.  Consistent with hypotheses 3 and 4, this 
suggests that formal mechanisms for information exchange and knowledge transfer among firms 
in the cluster enhanced their research productivity in the presence of greater of spillovers.
7  
Notably, in the absence of main effects for Firm R&D Alliances and Own Cluster Same 
Specialization R&D Alliances, the significant positive interactions of these variables with Firm in 
Strong Specialization indicate, strikingly, that R&D alliances enhanced innovative output only 
for firms located in clusters strong in their specialization.  These findings point to the significance 
of R&D alliances to a firm’s ability to exploit external knowledge; that is to its absorptive 
capacity.  
The other is that their access to knowledge spillovers in the informal networks and 
interactions that characterize strong R&D concentrations served as a partial substitute for access 
to information and ideas through formal employment relations.  As indicated by the combined 
significant positive Firm R&D employees main effect and significant negative Strong 
Specialization x Firm R&D Employees interaction effect, firms located in clusters strong in their 
own specialization actually benefited less  from their own R&D employees, consistent with 
hypothesis 3alt.  However, consistent with hypothesis 4alt, in the absence of main effect of Own 
Cluster Same Specialization R&D employees, the significant negative Strong Specialization x 
Firm R&D Employees interaction points to the limits of agglomeration – as a cluster’s strong 
specialization grew competition among firms for skilled R&D employees dampened the positive 
externalities generated by the R&D concentration. 
                                                 
7 Although our data do not permit us to determine where a firm’s R&D partners are located, other studies have 




Several of the control variable effects are also notable.  Among firm characteristics, 
corporate parents, a focus on human specializations, and recent patent applications increase 
patent application rates.  Firms with more R&D employees and greater financing also apply for 
patents at a higher rate.  Firms with greater revenues and more downstream alliances for 
manufacturing and distribution apply for fewer patents, likely because they are closer to or at the 
commercialization stage, and so expend less focused on innovative activity.  The negative effect 
for R&D expenditures is somewhat puzzling, but may also be attributable to a life-cycle effect – 
ceteris paribus, firms with greater R&D expenditures may be engaged in more basic research,   
and so to apply for fewer patents. In addition, when the firms’ research requires clinical trials 
before the product can be commercialized, and since clinical trials demand much of the firm’s 
resources, the firms are more inclined to focus their attention, at those stages, on the successive 
completion of the clinical trials phases rather than on new patents applications. Finally, a firm’s 
proximity within a cluster matters.  Firms that were a greater than average geographic distance 
from other firms in their cluster had lower patent application rates than firms that were more 
proximate.  For example, the patent application rate for a firm whose average distance was 10 
kilometers further than their cluster’s average was 10.4 percent below that of a firm at the 
average.   
Among own cluster same specializations characteristics, a firm’s patent application rate 
was higher when more same specialization university labs were located in its cluster.  IRAP 
grants to other firms in the same specialization also raised a firm’s patent application rate, 
suggesting a rising tide for all firms in specializations attractive to this government funding 
agency.  Greater financing of other firms in the same specialization, however, lowered a firm’s 
patent application rate, suggesting intra-cluster, intra-specialization competition for financial 
resources.  The negative effect of other same specialization firms’ upstream alliances may reflect 
either competition for access to scarce innovative capabilities of university, research institute, and 
government labs, or a life cycle effect (i.e., specializations characterized by a high frequency of 
upstream alliances are likely focused on early-stage research).  The negative effect of other same 
specialization firms’ downstream alliances likely reflects a life cycle effect since specializations 
characterized by a high frequency of downstream alliances are focused on commercialization, 
resulting in less resources being devoted to R&D. 




competition and commensalism.  There is evidence of competition in the negative coefficient for 
the number of other firms in other specializations in several models (see Models 6-7).  The 
coefficient for IRAP grants to firms in other specializations is, however, positive, suggesting a 
‘rising tide for all’ in clusters attractive to this government funding agency – regardless of 
specialization.  The positive coefficients for other specialization revenues and downstream 
alliances may reflect a life cycle effect: specializations with higher revenues and more 
downstream alliances are likely focused on commercialization, not on R&D.  
The effects of other cluster same specialization characteristics exhibit a distinct nature of 
inter-cluster competition, providing further evidence of the veracity of the clustering effects.  In 
particular, while recent patent applications and R&D expenditures by same specialization firms 
within a firm’s own cluster did not affect its patent application rate, recent patent applications and 
R&D expenditures by same specialization firms in other clusters lowered its rate of application.  
The negative effect of same specialization firms’ upstream alliances in other clusters may again 
reflect either a specialization-specific life cycle effect, or inter-cluster competition for access to 
scarce innovative capabilities of university, research institute, and government labs.  The positive 
coefficient for revenues of same specialization firms in other clusters may suggest the existence 
of national patent races as positive revenue in a technology spurs on additional inventive activity.   
 
Discussion and Conclusion 
This study set out to provide empirical evidence of the specific ways in which firms benefit from 
knowledge spillovers and externalities in industrial clusters.  A rich data enabled us to specify a 
detailed baseline model and examine the influence of a broader range of cluster characteristics on 
innovative output and to examine firms’ technological specializations in a very fine-grained way.  
The firm level controls, along with controls for industry activity in other specializations in the 
same cluster, and the same specialization in other clusters, help ensure that our clustering results 
are not spuriously capturing broader cluster-level, but not specialization-specific effects, as well 
as more diffuse (i.e., non-local) processes occurring at a national rather than cluster level. 
Our baseline results echo prior studies.  Clustered firms in the Canadian biotechnology 
industry are over eight times more innovative than non-clustered firms.  Within clusters, the 




firms apply for patents at more than twice the rate of other specialization firms located in the 
same cluster, as well as same specialization firms located in other clusters that are not strong in 
the specialization.  Thus, the more focused the innovative activity in a spatial area the greater the 
knowledge spillovers; the greatest gains from clustering are realized by locating within 
concentrations of firms with similar technological specializations.  In addition, we find evidence 
that location within the cluster matters: firms face a decrease in R&D productivity when they are 
less central to other firms in the cluster.  
Extending prior research, our findings indicate that the greater innovativeness of 
collocated firms of the same technological specialization may be attributed to their earning 
greater returns for R&D investments as a result of enhanced localized knowledge spillovers.  In 
particular, we found that location in a cluster strong in a firm’s technological specialization raises 
the productivity of its own R&D alliances and provides positive externalities gained from other 
firms’ R&D alliances.  In this manner, location serves as a partial substitute for access to 
information and ideas through formal employment relations.  Our results also suggest the limits 
of agglomeration economies in the form of increased competition for skilled R&D employees 
within a cluster’s strong technological specialization.    
Taken together, our findings indicate that the benefits a firm derives from collocating with 
other firms in the same specialization depend importantly on the firm’s ability to capitalize on 
available spillovers.  Our results thus indicate the importance of absorptive capacity and of the 
characteristics of the learning environment within the cluster to generating positive externalities 
from clustering.  As other firms in the cluster invest in R&D activity, the pool of new knowledge 
into which the firm can tap will be enhanced.  Of course, low-level R&D investment equilibria in 
which the level of new knowledge is too limited to motivate individual firms to invest are also 
possible. Thus, at the cluster level, there is evidence of increasing returns to R&D investment.  
Moreover, our results suggest that R&D alliances are a complement to geographic 
location: both provide access to knowledge and together they are mutually reinforcing.  The most 
engaged firms will source knowledge both locally and through strategic alliances to the benefit of 
their inventive activity.  For example, Owen-Smith and Powell (forthcoming) find that biotech 
firms located in Boston, perhaps the premier industrial cluster for this activity, engage in a large 
number of strategic alliances, many of them at long distance.  Greater absorptive capacity is the 




alliances of their neighbors. While Fontes (forthcoming) argues that strategic alliances may be 
used to compensate for geographic remoteness, our results suggest that R&D alliances generate 
higher returns when firms are located in clusters with firms working on similar applications. 
Our findings have policy implications for both firms and jurisdictions.  Many remote 
jurisdictions are investing resources in promoting the formation of biotech firms or attempting to 
recruit firms from other locations.  While the aspiration to capture an economically important 
new industry is understandable, our results suggest that these firms will be less productive in 
these locations.  By decreasing the natural tendency towards agglomeration, such efforts may 
operate to the determent of overall R&D productivity since an R&D investment in a remote firm 
will yield a lower return, all other things equal.   
While our study reveals some new and more fine-grained dimensions of the benefits of 
geographic clustering in general, and the greater innovativeness of firms located in clusters strong 
in their own technology specialization in particular, much work remains to be done.   
Unfortunately, the literature has a limited understanding of the factors responsible for achieving 
critical and self-sustaining mass of firms within clusters.  The logic of increasing returns suggests 
that only a few places will be able to sustain clusters in specific technological applications over 
the long run.  Examining the development of an industry under a combined temporal-spatial-
technological lens should help to address these larger questions.       
Evidence is mounting that localized knowledge externalities or spillovers associated with 
industrial clustering are critical to innovation and the geographic distribution of economic value 
creation.  Although we understand the properties and influences of clustering increasingly well, 
we need a better understanding of the processes and mechanisms underlying their innovation-
enhancing properties.  We hope our analysis of differences in the returns to a firm’s own and 
other firms’ R&D activities for firms located in clusters strong in their technological 
specialization relative to firms located in clusters that are not strong in their technological 
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Figure 1. Density of Firms located within Geographic Clusters of Biotechnology Firms in 










































Figure 2.  Concentration of Technological Specialization Activity by Cluster. 
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